Rebound of weight gain following topiramate cessation.
Khazaal
Y
Y
Zullino
D F
DF
D000328:Adult; D019440:Anti-Obesity Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005247:Feeding Behavior; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009765:Obesity / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D000077236:Topiramate; D015430:Weight Gain
D019440:Anti-Obesity Agents; D000077236:Topiramate; D005632:Fructose